Physician profile
Boris Ioffe
NPI 1598949646
$29,521.28
in general payments reported to CMS, 2019-2025
38 companies · $5,022 in 2025
The $5,022 reported for 2025 was more than what 90% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,809 · 2020: $2,773 · 2021: $3,572 · 2022: $4,761 · 2023: $4,183 · 2024: $4,400 · 2025: $5,022.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K · Education: $64.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,540.53 |
| Education | $64.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $4,130.75 | 2019-2025 | |
| Genzyme Corporation | $2,914.90 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $2,883.24 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $2,743.21 | 2019-2025 | Ilumya, Blu-U, Odomzo |
| Regeneron Healthcare Solutions, INC. | $1,868.35 | 2019-2025 | Dupixent, Libtayo |
| Lilly USA, LLC | $1,821.67 | 2019-2025 | Olumiant, Ebglyss, Taltz |
| Ucb, INC. | $1,679.28 | 2019-2025 | Bimzelx, Cimzia |
| Janssen Biotech, INC. | $1,299.77 | 2019-2025 | Tremfya, Stelara, Simponi Aria |
| Amgen INC. | $1,080.26 | 2019-2025 | Otezla, Otezla |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $1,052.15 | 2019-2025 | Arazlo, Targretin, Jublia |
| Galderma Laboratories, L.P. | $1,000.64 | 2019-2025 | Nemluvio, Aklief, Oracea |
| Pfizer INC. | $908.71 | 2019-2025 | |
| Leo Pharma INC. | $898.30 | 2019-2025 | Anzupgo, Adbry, Spevigo |
| E.R. Squibb & Sons, L.L.C. | $834.19 | 2022-2025 | Sotyktu |
| Biofrontera INC. | $654.18 | 2019-2023 | Ameluz, Xepi, Bf-Rhodoled |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Boris Ioffe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.